Optimizing AVF creation prior to dialysis start: the role of predialysis renal replacement therapy choices.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 22962410)

Published in Nephrol Dial Transplant on September 07, 2012

Authors

Jennifer Hanko1, Alexandra Romann, Paul Taylor, Michael Copland, Monica Beaulieu

Author Affiliations

1: Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada. jennifer.hanko@belfasttrust.hscni.net

Articles by these authors

Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature (2002) 37.66

Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol (2007) 8.16

The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27

Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol (2004) 3.45

Insights into antifolate resistance from malarial DHFR-TS structures. Nat Struct Biol (2003) 3.20

Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis (2008) 2.64

Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure. Kidney Int (2005) 2.29

Predictive adaptive responses to maternal high-fat diet prevent endothelial dysfunction but not hypertension in adult rat offspring. Circulation (2004) 2.28

Intensive hemodialysis associates with improved survival compared with conventional hemodialysis. J Am Soc Nephrol (2012) 2.15

Dialysate calcium concentration and mineral metabolism in long and long-frequent hemodialysis: a systematic review and meta-analysis for a Canadian Society of Nephrology clinical practice guideline. Am J Kidney Dis (2013) 2.07

Use of a computerized guideline for glucose regulation in the intensive care unit improved both guideline adherence and glucose regulation. J Am Med Inform Assoc (2004) 1.85

Clinical Practice Guidelines and Recommendations on Peritoneal Dialysis Adequacy 2011. Perit Dial Int (2011) 1.76

Computer-aided detection in the United Kingdom National Breast Screening Programme: prospective study. Radiology (2005) 1.63

Structural and biochemical studies of human proliferating cell nuclear antigen complexes provide a rationale for cyclin association and inhibitor design. Proc Natl Acad Sci U S A (2005) 1.57

The cost of starting and maintaining a large home hemodialysis program. Kidney Int (2010) 1.53

Mechanism of Mos1 transposition: insights from structural analysis. EMBO J (2006) 1.48

Inhibitors of Polo-like kinase reveal roles in spindle-pole maintenance. Nat Chem Biol (2006) 1.47

Global proteomic assessment of the classical protein-tyrosine phosphatome and "Redoxome". Cell (2011) 1.34

Thymidylate synthase expression and outcome of patients receiving pemetrexed for advanced nonsquamous non-small-cell lung cancer in a prospective blinded assessment phase II clinical trial. J Thorac Oncol (2013) 1.17

Diabetes, kidney disease and cardiovascular disease patients. Assessing care of complex patients using outpatient testing and visits: additional metrics by which to evaluate health care system functioning. Nephrol Dial Transplant (2009) 1.17

S-nitrosylation of AtSABP3 antagonizes the expression of plant immunity. J Biol Chem (2008) 1.16

Dietary soy isoflavone induced increases in antioxidant and eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo. FASEB J (2005) 1.14

A structure-based mutational analysis of cyclophilin 40 identifies key residues in the core tetratricopeptide repeat domain that mediate binding to Hsp90. J Biol Chem (2002) 1.13

Patient and technique survival among a Canadian multicenter nocturnal home hemodialysis cohort. Clin J Am Soc Nephrol (2010) 1.13

Visuomotor priming by pictures of hand postures: perspective matters. Neuropsychologia (2003) 1.12

Octaheme tetrathionate reductase is a respiratory enzyme with novel heme ligation. Nat Struct Mol Biol (2004) 1.10

Effect of high-dose intravenous vitamin C on inflammation in cancer patients. J Transl Med (2012) 1.09

A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients. P R Health Sci J (2005) 1.08

Multi-intervention management of calciphylaxis: a report of 7 cases. Am J Kidney Dis (2011) 1.08

Epidermal growth factor receptor phosphorylation sites Ser991 and Tyr998 are implicated in the regulation of receptor endocytosis and phosphorylations at Ser1039 and Thr1041. Mol Cell Proteomics (2009) 1.07

Homologues of human macrophage migration inhibitory factor from a parasitic nematode. Gene cloning, protein activity, and crystal structure. J Biol Chem (2002) 1.04

Expression, purification and preliminary crystallographic studies of a single-point mutant of Mos1 mariner transposase. Acta Crystallogr D Biol Crystallogr (2004) 1.03

A systematic review of computer-assisted diagnosis in diagnostic cancer imaging. Eur J Radiol (2011) 1.02

Selected Reaction Monitoring (SRM) Analysis of Epidermal Growth Factor Receptor (EGFR) in Formalin Fixed Tumor Tissue. Clin Proteomics (2012) 1.01

Making decisions about mammography. BMJ (2005) 0.99

Measurement of protein phosphorylation stoichiometry by selected reaction monitoring mass spectrometry. J Proteome Res (2010) 0.99

Structures of immunophilins and their ligand complexes. Curr Top Med Chem (2003) 0.98

Crystal structure of a thermostable lipase from Bacillus stearothermophilus P1. J Mol Biol (2002) 0.98

System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastoma. Clin Cancer Res (2010) 0.97

EDULISS: a small-molecule database with data-mining and pharmacophore searching capabilities. Nucleic Acids Res (2010) 0.96

Discovery of a novel family of CDK inhibitors with the program LIDAEUS: structural basis for ligand-induced disordering of the activation loop. Structure (2003) 0.96

Intravenous ascorbic acid: protocol for its application and use. P R Health Sci J (2003) 0.96

Multiple myeloma phosphotyrosine proteomic profile associated with FGFR3 expression, ligand activation, and drug inhibition. Proc Natl Acad Sci U S A (2009) 0.96

Outcomes of a provincial home haemodialysis programme--a two-year experience: establishing benchmarks for programme evaluation. Nephrol Dial Transplant (2008) 0.94

Canadian Society of Nephrology guidelines for the management of patients with ESRD treated with intensive hemodialysis. Am J Kidney Dis (2013) 0.94

Utility and cost of a renal transplant transition clinic. Pediatr Nephrol (2011) 0.93

Molecular basis for Jagged-1/Serrate ligand recognition by the Notch receptor. J Biol Chem (2013) 0.92

Regional implementation of creatinine measurement standardization. J Am Soc Nephrol (2007) 0.92

Tandem immunoprecipitation of phosphotyrosine-mass spectrometry (TIPY-MS) indicates C19ORF19 becomes tyrosine-phosphorylated and associated with activated epidermal growth factor receptor. J Proteome Res (2008) 0.91

Responsiveness of FGF-23 and mineral metabolism to altered dietary phosphate intake in chronic kidney disease (CKD): results of a randomized trial. Nephrol Dial Transplant (2012) 0.91

nemy encodes a cytochrome b561 that is required for Drosophila learning and memory. Proc Natl Acad Sci U S A (2008) 0.91

Identification and selected reaction monitoring (SRM) quantification of endocytosis factors associated with Numb. Mol Cell Proteomics (2012) 0.91

Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signatures. J Proteome Res (2010) 0.91

Emerging applications for phospho-proteomics in cancer molecular therapeutics. Biochim Biophys Acta (2006) 0.91

Maternal obesity programmes offspring development of non-alcoholic fatty pancreas disease. Biochem Biophys Res Commun (2010) 0.88

Omitting elective nodal irradiation during thoracic irradiation in limited-stage small cell lung cancer--evidence from a phase II trial. Lung Cancer (2011) 0.88

Distinct properties of murine alpha 5 gamma-aminobutyric acid type a receptors revealed by biochemical fractionation and mass spectroscopy. J Neurosci Res (2009) 0.88

Liquid chromatography-tandem mass spectrometry or automated immunoassays: what are the future trends in therapeutic drug monitoring? Clin Chem (2012) 0.87

Identification of protein binding surfaces using surface triplet propensities. Bioinformatics (2010) 0.86

The effects of the odstock drop foot stimulator on perceived quality of life for people with stroke and multiple sclerosis. Neuromodulation (2010) 0.86

Odin (ANKS1A) modulates EGF receptor recycling and stability. PLoS One (2013) 0.86

Utility and limitations of a multicenter nocturnal home hemodialysis cohort. Clin J Am Soc Nephrol (2008) 0.86

Accelerometer-triggered electrical stimulation for reach and grasp in chronic stroke patients: a pilot study. Neurorehabil Neural Repair (2011) 0.85

A phase I study of Vandetanib in combination with vinorelbine/cisplatin or gemcitabine/cisplatin as first-line treatment for advanced non-small cell lung cancer. J Thorac Oncol (2010) 0.85

Use of G-CSF during concurrent chemotherapy and thoracic radiotherapy in patients with limited-stage small-cell lung cancer safety data from a phase II trial. Lung Cancer (2011) 0.85

Vascular access for intensive maintenance hemodialysis: a systematic review for a Canadian Society of Nephrology clinical practice guideline. Am J Kidney Dis (2013) 0.84

Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung Cancer. J Thorac Oncol (2015) 0.84

Atypical (RIO) protein kinases from Haemonchus contortus--promise as new targets for nematocidal drugs. Biotechnol Adv (2011) 0.84

The major cystic fibrosis causing mutation exhibits defective propensity for phosphorylation. Proteomics (2014) 0.83

The British Columbia Nephrologists' Access Study (BCNAS) - a prospective, health services interventional study to develop waiting time benchmarks and reduce wait times for out-patient nephrology consultations. BMC Nephrol (2013) 0.83

Collapsing glomerulopathy coexisting with membranous glomerulonephritis in native kidney biopsies: a report of 3 HIV-negative patients. Am J Kidney Dis (2003) 0.82

Vascular access planning in peritoneal dialysis patients. Perit Dial Int (2008) 0.82

Long C terminal splice variant CaV2.2 identified in presynaptic membrane by mass spectrometric analysis. Channels (Austin) (2010) 0.82

Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer. J Proteome Res (2011) 0.81

A temporal examination of the planktonic and biofilm proteome of whole cell Pseudomonas aeruginosa PAO1 using quantitative mass spectrometry. Mol Cell Proteomics (2014) 0.81

Expression, purification, crystallization and preliminary crystallographic analysis of a thermostable lipase from Bacillus stearothermophilus P1. Acta Crystallogr D Biol Crystallogr (2001) 0.81

Novel biomarkers do not correlate with severity of vascular stiffness in CKD patients with severe co-morbid disease. Nephron Clin Pract (2011) 0.81

Proteomic profiles of human lung adeno and squamous cell carcinoma using super-SILAC and label-free quantification approaches. Proteomics (2014) 0.81

Identification of paediatric tuberculosis from airway shape features. Med Image Comput Comput Assist Interv (2011) 0.80

Towards rational approaches of health care utilization in complex patients: an exploratory randomized trial comparing a novel combined clinic to multiple specialty clinics in patients with renal disease-cardiovascular disease-diabetes. Nephrol Dial Transplant (2011) 0.80

Caldicott 2 and patient data. BMJ (2013) 0.80

Analytical and preparative instrumentation. J Biomol Screen (2013) 0.80

Evaluation of PROforma as a language for implementing medical guidelines in a practical context. BMC Med Inform Decis Mak (2006) 0.80

Structure-based discovery of a family of synthetic cyclophilin inhibitors showing a cyclosporin-A phenotype in Caenorhabditis elegans. Biochem Biophys Res Commun (2007) 0.79

Vascular stiffness in incident peritoneal dialysis patients over time. Clin Nephrol (2012) 0.79

Association of raised titres of antibodies to Chlamydia pneumoniae with a history of pre-eclampsia. BJOG (2005) 0.79

Proteomic profiling of the planarian Schmidtea mediterranea and its mucous reveals similarities with human secretions and those predicted for parasitic flatworms. Mol Cell Proteomics (2012) 0.79

Adenosquamous carcinoma of the lung diagnosed by cytology?: a diagnostic dilemma. Diagn Cytopathol (2011) 0.79

Prevalence and incidence of hepatitis C virus in hemodialysis patients in British Columbia: Follow-up after a possible breach in hemodialysis machines. Can J Infect Dis Med Microbiol (2009) 0.79

An implantable two channel drop foot stimulator: initial clinical results. Artif Organs (2002) 0.79

Proteomics in Vaccinology and Immunobiology: An Informatics Perspective of the Immunone. J Biomed Biotechnol (2003) 0.79

Rationale for a home dialysis virtual ward: design and implementation. BMC Nephrol (2014) 0.78

Recommendations for research design and reporting in computer-assisted diagnosis to facilitate meta-analysis. J Biomed Inform (2011) 0.77

Construction of an odds model of coronary heart disease using published information: the Cardiovascular Health Improvement Model (CHIME). BMC Med Inform Decis Mak (2008) 0.77

Structural and biological characterisation of the gut-associated cyclophilin B isoforms from Caenorhabditis elegans. J Mol Biol (2002) 0.77